The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
Abstract
OBJECTIVE: The authors evaluated the relative efficacy and safety of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome in children and adolescents. METHOD: A double-blind, 24-week, placebo-controlled double crossover study of equivalent dose formulations of haloperidol and pimozide was conducted with 22 subjects, aged 7-16 years, with Tourette's disorder who were randomly assigned to first one active drug treatment and then the other. Biweekly assessment and flexible dose titration mimicked clinical practice. The primary outcome variable was total score on the Tourette Syndrome Global Scale. Final outcome was determined after 6 weeks of each treatment (placebo, pimozide, haloperidol), with a 2-week placebo baseline period and intervening 2-week placebo washout periods between treatments. RESULTS: Pimozide proved significantly different from placebo in affecting the primary outcome variable, whereas haloperidol failed to have a significant effect. Haloperidol exhibited a threefold higher frequency of serious side effects and significantly greater extrapyramidal symptoms relative to pimozide. Haloperidol-associated treatment-limiting adverse events were experienced by 41% of the patients. The therapeutic doses of pimozide and haloperidol were equivalent (mean = 3.4 mg/day, SD = 1.6, and mean = 3.5 mg/day, SD = 2.2, respectively). CONCLUSIONS: At equivalent doses, pimozide is superior to haloperidol for controlling symptoms of Tourette's disorder in children and adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A haloperidol and pimozide placebo-controlled crossover trial found pimozide to be more effective at reducing total number of tics and to be better tolerated as compared with haloperidol.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [99]
In the citing paper
“Haloperidol has been shown to be effective in several randomized controlled trials (RCTs); however, up to 84% of patients have experienced adverse events with roughly onethird having extrapyramidal side effects.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Chambers, W. J. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300064008 · Cited by 1,269
The Two-Period Change-Over Design and Its Use in Clinical Trials
Grizzle, J. E. (1965) · Biometrics · doi:10.2307/2528104 · Cited by 784
The use of the „studentized range” in connection with an analysis of variance
Keuls, M. (1952) · Euphytica · doi:10.1007/bf01908269 · Cited by 635
Shapiro, E. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080052006 · Cited by 355
Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
Blandina, P., Goldfarb, J., Craddock-Royal, B., & Green, J. P. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21081-3 · Cited by 240
An Epidemiologic Study of Gilles de la Tourette's Syndrome in Israel
Apter, A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210068008 · Cited by 196
A New Instrument for Clinical Studies of Tourette's Syndrome
HARCHERIK, D. F., LECKMAN, J. F., DETLOR, J., & COHEN, D. J. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1097/00004583-198403000-00006 · Cited by 193
Tourette Syndrome and Other Tic Disorders Diagnosis, Pathophysiology, and Treatment
SINGER, H. S., & WALKUP, J. T. (1991) · Medicine · doi:10.1097/00005792-199101000-00002 · Cited by 190
The natural history of Tourette syndrome: A follow‐up study
Erenberg, G., Cruse, R. P., & David Rothner, A. (1987) · Annals of Neurology · doi:10.1002/ana.410220317 · Cited by 175
A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome
Ross, M. S., & Moldofsky, H. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.5.585 · Cited by 158
School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder
Mikkelsen, E. J., DETLOR, J., & Cohen, D. J. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1572 · Cited by 127
BRUUN, R. D. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.621 · Cited by 126
The validity of instruments measuring tic severity in Tourette's syndrome
WALKUP, J. T., ROSENBERG, L. A., BROWN, J., & SINGER, H. S. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199205000-00013 · Cited by 117
Richardson, M. A., Haugland, G., & Craig, T. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1322 · Cited by 88
Mental health needs associated with Tourette syndrome.
STEFL, M. E. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.12.1310 · Cited by 79
Treatment of Gilles de la Tourette syndrome with pimozide
Shapiro, A. K., Shapiro, E., & Eisenkraft, G. J. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.9.1183 · Cited by 71
Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard, G., Annable, L., Ross‐Chouinard, A., & Kropsky, M. L. (1979) · PubMed · Cited by 60
The Pharmacologic Treatment of Tic Disorders
Chappell, P. B., Leckman, J. F., & Riddle, M. A. (1995) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30457-7 · Cited by 59
Haloperidol-induced dysphoria in patients with Tourette syndrome
Caine, E. D., & Rj, P. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.9.1216 · Cited by 46
Testing Hypotheses in the Two‐period Change‐over with Binary Data
Zimmermann, H., & Rahlfs, V. W. (1978) · Biometrical Journal · doi:10.1002/bimj.4710200207 · Cited by 44
Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide
Tecott, L. H., Kwong, L. L., Uhr, S. B., & Peroutka, S. J. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90219-2 · Cited by 33
Persistent Tardive Dyskinesia and Other Neuroleptic-Related Dyskinesias in Tourette's Disorder
Silva, R. R., Magee, H., & Friedhoff, A. J. (1993) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1993.3.137 · Cited by 32
Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome
Sallee, F. R., Dougherty, D., Sethuraman, G., & Vrindavanam, N. S. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00596-x · Cited by 26
Genetics, haloperidol and pimozide: a comparative study in two mouse strains.
Messiha, F. S. (1991) · PubMed · Cited by 3
Cited by
Tourette syndrome, associated conditions and the complexities of treatment
Robertson, M. M. (2000) · Brain · doi:10.1093/brain/123.3.425 · Cited by 704
Leckman, J. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11526-1 · Cited by 685
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Jankovic, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010032 · Cited by 447
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1997-08-01
- Volume
- 154
- Issue
- 8
- Pages
- 1057-1062
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W120122032
- Cited by
- 268
- References
- 26
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.